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Three features of the cause of rare diseases may be
important for the future of the movement.
1. The category of rare diseases was originally created
to remedy the problem caused by orphan drugs in the
USA. The 1962 Kefauver-Harris amendments to the
Food, Drug and Cosmetic Act required the company
wanting to market a drug to prove its efficacy. Each
drug had to be (retroactively) tested. Drugs that had not
been tested however remained in hospital pharmacies,
and were called “homeless” or “orphan”. Meanwhile,
some U.S. patients were forced to discontinue their
treatment. In the 1970s, these two phenomena pushed
the FDA to try and find a status for the drugs that,
although they had been developed, were not available
for the patients. Defining these drugs as drugs for rare
diseases appeared as the solution. This was the begin-
ning of the rare diseases movement.
2. Facing a rare disease, the patients and their families
often feel isolated. A series of interviews with 29 French
patients and 15 relatives who were affected by one of 6
rare disorders suggests that, once illness has become an
important aspect in the life of a person with a rare dis-
ease, or a of person related to one with a rare disease,
this person will try to meet other people in the same
situation.
3. Rare disease organizations are issue-based (people
gather to struggle with common problems that they want
to solve together) while coalitions of such organisations
tend to be rarity-based (organisations come together
because their members address rare disorders). A series of
61 interviews with patients, relatives, volunteers and
employees in 8 French associations identified three soli-
darity principles for these coalitions: (1) the “one for all”
principle, where any advancement for one disorder will
benefit many others; (2) the “every man for himself”
principle, where one should support their own rare disor-
der organisation; (3) the “all for one” principle, where soli-
darity is moral. None of these principles is satisfying.
Gathering people with/or related to rare disorders with
others addressing the same issues, i.e. an issue-based
approach in ad-hoc coalitions, has the potential to be
strong and cohesive. E.g.: coalitions of rare disease associa-
tions with Aids or cancer associations for access to insur-
ance or credit.
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